Asterias Biotherapeutics, Inc. 4
4 · Asterias Biotherapeutics, Inc. · Filed Jun 7, 2017
Insider Transaction Report
Form 4
Spink Katharine E.
Vice President & COO
Transactions
- Tax Payment
Common Stock
2017-06-05$3.20/sh−7,260$23,232→ 10,949 total
Holdings
- 192,500
Stock Option
Exercise: $2.34From: 2013-08-01Exp: 2020-03-09→ Common Stock (192,500 underlying) - 100,000
Stock Option
Exercise: $3.90From: 2016-02-12Exp: 2025-02-12→ Common Stock (100,000 underlying) - 100,000
Stock Option
Exercise: $5.45From: 2015-12-31Exp: 2025-11-04→ Common Stock (100,000 underlying) - 165,000
Stock Option
Exercise: $3.64From: 2017-02-26Exp: 2026-02-26→ Common Stock (165,000 underlying) - 150,000
Stock Options
Exercise: $3.45From: 2018-03-30Exp: 2027-03-30→ Common Stock (150,000 underlying)
Footnotes (6)
- [F1]In accordance with Rule 16b-3, represents shares withheld by the Issuer to satisfy tax withholding obligation upon vesting of a previously reported restricted stock award.
- [F2]Of such stock options, 4,167 have vested not as of the date hereof.
- [F3]Of such stock options, 43,751 have vested not as of the date hereof.
- [F4]Of such stock options, 62,500 have vested not as of the date hereof.
- [F5]Of such stock options, 113,438 have not vested as of the date hereof.
- [F6]Of such stock options, 150,000 have not vested as of the date hereof.